Algeria has signed a contract with an Indian laboratory which produces the AstraZeneca vaccine for the purchase of 800,000 doses, expected in the coming days, said, on Tuesda,y Ms. Ouahiba Hadjoudj, director of Pharmacy and Medical Equipment at the Ministry of Health, Population and Hospital Reform.
Other vaccines will also be purchased as part of the COVAX system. To this end, procedures are being taken to provide all the documents necessary for the operation, added the ministry official.
Speaking during a parliamentary day devoted to the pandemic and Covid-19 vaccination strategy, the ministry director announced “ongoing negotiations with other laboratories for the purchase of other batches of vaccine to ensure health coverage for ‘all Algerians “.
Earlier on February 1st, , the first batch, composed of 50,000 doses of the Anglo-Swedish vaccine AstraZeneca, which was fabricated in India, arrived in the Houari-Boumediene International Airport (Algiers) onboard a Qatar Airways flight.
Noting that this vaccine was fabricated in India and dedicated to Algeria. Both countries maintain solid relations of fraternity and friendship drawn from a long common militant journey. Their Diplomatic relations were established in 1962, the year Algeria became independent from colonial rule from France. Since then, relations between the two countries have been cordial. The two nations support each other on vital issues at bilateral and multilateral levels.
Following the acquisition of the consignments of made-in-India vaccines, the Indian External Affairs Minister S Jaishankar tweeted, using the hashtag ‘Vaccine Maitri’: “Arrival in Algeria. A trusted partnership stands renewed.”
It is worth recalling that India has already sent COVID-19 vaccines to many countries such as: Bhutan, Maldives, Bangladesh, Brazil and Nepal, South Africa, among others, especially that this country, known as, “the Pharmacy of the World” is one of the world’s biggest drugmakers, and an increasing number of countries have already approached it for procuring the coronavirus vaccines.
For its part, the Indian Pharmaceutical Alliance highlighted that Indian companies are producing up to half of the world’s vaccine supply, mostly for developing nations so as to allow them acquire this vaccine to stem the spread of the pandemic.
Based on the vision of the Indian PM to respond positively to the requests of different countries on the globe, India intends to authorize two other vaccines in the next few months, added to the two already authorized, namely; one licensed from Oxford University and AstraZeneca and another developed at home by Bharat Biotech in partnership with the state-run Indian Council of Medical Research.